Condition: Brain Tumor, Recurrent · Brain Tumor · Brain Tumor, Primary · Sponsor: GT Medical Technologies, Inc.
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
This description comes directly from the study's public registry record.
Michael A. Garcia, MD, MS · (833) 662-0044 · mgarcia@gtmedtech.com
Sita Patel, PhD, PharmD · (833)662-0044 · spatel@gtmedtech.com
Always discuss trial participation with your own doctor first.
| HonorHeath Scottsdale Osborn Medical Center | Phoenix, Arizona, United States | Recruiting |
| University of Arkansas Medical Center | Little Rock, Arkansas, United States | Recruiting |
| Eden Medical Center | Castro Valley, California, United States | Recruiting |
| UCSD Moores Cancer Center | La Jolla, California, United States | Recruiting |
| MemorialCare Health System | Laguna Hills, California, United States | Recruiting |
| Desert Regional Medical Center | Palm Springs, California, United States | Recruiting |
| California Pacific Medical Center, Sutter health | San Francisco, California, United States | Recruiting |
| Centura | Denver, Colorado, United States | Not Yet Recruiting |
| Colorado Brain & Spine Institute: Swedish Campus | Englewood, Colorado, United States | Recruiting |
| BayCare Health | Clearwater, Florida, United States | Recruiting |
| Ascension St. Vincent's | Jacksonville, Florida, United States | Recruiting |
| Miami Cancer Institute, Baptist Health South Florida | Miami, Florida, United States | Recruiting |
+ 42 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04427384